COVID‐19 pandemic and allergen immunotherapy—an EAACI survey

BACKGROUND: As in many fields of medical care, the coronavirus disease 2019 (COVID‐19) resulted in an increased uncertainty regarding the safety of allergen immunotherapy (AIT). Therefore, the European Academy of Allergy and Clinical Immunology (EAACI) aimed to analyze the situation in different cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaar, Oliver, Agache, Ioana, Bonini, Matteo, Brough, Helen Annaruth, Chivato, Tomás, Del Giacco, Stefano R., Gawlik, Radoslaw, Gelincik, Aslı, Hoffmann‐Sommergruber, Karin, Jutel, Marek, Klimek, Ludger, Knol, Edward F., Lauerma, Antti, Ollert, Markus, O’Mahony, Liam, Mortz, Charlotte G., Palomares, Oscar, Riggioni, Carmen, Schwarze, Jürgen, Skypala, Isabel, Torres, María José, Untersmayr, Eva, Walusiak‐Skorupa, Jolanta, Chaker, Adam, Giovannini, Mattia, Heffler, Enrico, Jensen‐Jarolim, Erika, Quecchia, Cristina, Sandoval‐Ruballos, Mónica, Sahiner, Umit, Tomić Spirić, Vesna, Alvaro‐Lozano, Montserrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013670/
https://www.ncbi.nlm.nih.gov/pubmed/33655519
http://dx.doi.org/10.1111/all.14793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013670/
https://www.ncbi.nlm.nih.gov/pubmed/33655519
http://dx.doi.org/10.1111/all.14793

Ejemplares similares